Analyst Price Target is $79.80
▲ +13.13% Upside Potential
This price target is based on 9 analysts offering 12 month price targets for Alcon in the last 3 months. The average price target is $79.80, with a high forecast of $92.00 and a low forecast of $68.80. The average price target represents a 13.13% upside from the last price of $70.54.
Current Consensus is
Hold
The current consensus among 9 polled investment analysts is to hold stock in Alcon. This rating changed within the last month from a Buy consensus rating.
Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the following segments: Surgical and Vision Care. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner on 1945 and is headquartered in Geneva, Switzerland.
Read More